The direct inhibition of estrogen synthesis targeting aromatase inhibition is considered to be an effective strategy towards breast cancer treatment (Altundag and Ibrahim, 2006[1]; Brueggemeier et al., 2005[5]; Favia et al., 2013[12]). The gene discussed is CYP19A1; the disease is breast cancer.